This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Gachon University of Industry-Academic Cooperation Foundation, Gil Medical Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 70 
1 out of 25 Years Active: 2025
Title: Hojung Choi: Innovator in Pharmaceutical Compounds
Introduction
Hojung Choi is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of novel compounds.
Latest Patents
Hojung Choi holds a patent for a 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof. This invention relates to a novel compound that exhibits GDH activity, making it effective for the prevention or treatment of obesity, diabetes, or fatty liver. His work in this area highlights the potential for new therapeutic options in managing these prevalent health issues.
Career Highlights
Throughout his career, Hojung Choi has been associated with reputable institutions such as Gachon University of Industry-Academic Cooperation Foundation and Gil Medical Center. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hojung Choi has collaborated with notable colleagues, including Dongyun Shin and Cheol Soo Choi. These partnerships have likely enriched his research endeavors and fostered innovation in his field.
Conclusion
Hojung Choi's contributions to pharmaceutical innovation, particularly through his patented compound, demonstrate his commitment to addressing critical health challenges. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile